Assessment of the efficacy of hydrogel-based wound dressing containing allantoin and silver nanoparticles in the treatment of second-degree burn wounds: A randomized clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新: 2022年5月2日

适应症

试验速览

暂无简介。

•Patients between the ages of 2 and 60 are eligible to participate.
•Patients with second-degree burns diagnosed by the relevant physician
•Patients with burns that are less than or equal to 20%
•Patient with second-degree burns in upper and lower limbs and anterior trunk
•The wound is examined by a plastic and burn surgeon for necrosis and the depth of the burn. If the burned area is not a candidate for early surgery and can be healed without surgery and with minimal complications, the patient will be eligible to the study.

•Delayed visit and the presence of obvious wound infection at the first visit by an infectious disease specialist
•Patients who are receiving chemotherapy
•Patients taking corticosteroids or cytotoxic medicines
•Cancer, cytotoxic drugs, immunosuppressants, and the presence of chronic diseases other than diabetes that affect wound healing, such as severe vascular disease, lupus, rheumatoid arthritis, and renal failure
•The presence of an underlying disease leads to a defective immune system
•Diabetic patients
•Taking drugs that lead to a defective immune system.
•Burns in the back of the trunk, face, head and perineum

发起方